Ping An Good Doctor Debuts on HKEX, Raises $1.1 Billion in Landmark AI Healthcare IPO

On May 4, Ping An Healthcare and Technology Company Limited (hereinafter referred to as “Ping An Good Doctor,” stock code: 1833.HK) was listed on the Main Board of The Stock Exchange of Hong Kong, marking the official debut of the world’s first AI-driven healthcare technology company. Ma Mingzhe, Chairman and CEO of Ping An Group, attended the listing ceremony together with Wang Tao, Chairman and CEO of Ping An Good Doctor, and other senior executives, jointly witnessing this milestone moment for Ping An Good Doctor.

Ping An Group Chairman and CEO Ma Mingzhe, Ping An Good Doctor Chairman and CEO Wang Tao ring the listing bell (Source: Provided by the company)

Ping An Good Doctor opened at HK$57.30 per share, up 4.6% from its issue price, with a total market capitalization exceeding HK$60 billion. Previous announcements indicated that Ping An Good Doctor’s issue price was HK$54.80 per share, with 160 million shares offered, aiming to raise HK$8.564 billion (approximately US$1.1 billion). This marks the largest IPO on the Hong Kong Stock Exchange year-to-date.

The prospectus indicates that Ping An Good Doctor intends to allocate 40% of the net proceeds from this offering to business expansion; 30% to investments, acquisitions of domestic companies, strategic collaborations with domestic entities, and overseas expansion initiatives; 20% to the development of information infrastructure, AI-enabled solutions, and other technologies; and 10% to working capital and general corporate purposes.

In an interview with the media, Wang Tao pointed out that the initial public offering (IPO) marks another significant milestone in the company’s development. Ping An Good Doctor will leverage its successful listing on the Hong Kong Stock Exchange as an opportunity to usher in a new chapter of rapid growth. With a mission to build the world’s largest one-stop healthcare ecosystem, Ping An Good Doctor is committed to leveraging technology to improve human health. Guided by this mission, the company aims to provide every family with a family doctor, create an electronic health record for each individual, and formulate a personalized health management plan. Looking ahead, the company will adopt a more transparent, open, and proactive approach to establishing Ping An Good Doctor as an internet healthcare platform with global influence, delivering long-term and competitive returns to its supportive shareholders through outstanding performance.

Analysts believe that, as a platform-level gateway for healthcare services, Ping An Good Doctor shoulders the critical responsibility of the “Healthcare” pillar within Ping An Group’s five major strategic sectors: “Healthcare, Food, Housing, Transportation, and Entertainment.” The successful listing of Ping An Good Doctor is therefore of significant importance to Ping An Group. Moreover, its IPO marks the debut of the world’s first AI-driven medical technology stock, a pioneering milestone that will lead the mobile health wave in China and globally, ushering in a new era of mobile health technology.

The spin-off and listing of subsidiaries under Ping An Group is a major event that has drawn significant attention from global capital markets this year, with Ping An Good Doctor successfully firing the first shot.

Ping An Good Doctor’s Hong Kong IPO has garnered recognition from all quarters. In late January 2018, the company filed its listing application with the Hong Kong Stock Exchange, thereby making its first public disclosure of the achievements and challenges it has faced in areas such as technology research and development, user acquisition, and revenue performance.

According to the prospectus, Ping An Good Doctor completed two rounds of financing prior to its IPO. In late April 2016, it closed its Series A financing round, raising $500 million at a post-money valuation of $3 billion. In December 2017, during its Pre-IPO financing round, SoftBank’s Vision Fund invested $400 million at a post-money valuation of $5.4 billion. Both financing rounds set records in the internet healthcare sector, establishing Ping An Good Doctor as the largest “unicorn” in China’s internet healthcare industry.

During the public offering phase, Ping An Good Doctor introduced seven top-tier global cornerstone investors: BlackRock, the Government of Singapore Investment Corporation (GIC), the Canada Pension Plan Investment Board (CPPIB), Capital Group, Khazanah Nasional Berhad, Charoen Pokphand International Holdings Limited, and Swiss Re. Furthermore, Ping An Good Doctor was oversubscribed by 654 times, with over HK$376.8 billion in frozen funds, ranking eleventh on the list of Hong Kong IPOs with the highest amount of frozen capital.

Analysts pointed out that Ping An Good Doctor’s IPO has gained widespread recognition, largely due to its business model as the “Alibaba of Healthcare.” Moreover, as the world’s first publicly listed AI healthcare technology company, its listing may usher in a new era for internet-based healthcare.

Just as the e-commerce model pioneered by Alibaba represents a market worth trillions, the healthcare sector in which Ping An Good Doctor operates also boasts vast potential. Although it was not the earliest entrant in the internet healthcare space, Ping An Good Doctor has emerged as the leading player in the field after four years of relentless effort.

Measured by average monthly active users and daily average online consultations, Ping An Good Doctor is currently the largest internet healthcare platform in China. During the 2018 Spring Festival, Ping An Good Doctor’s registered users surpassed the 200 million mark, with average monthly active users exceeding 30 million and daily consultations nearing 400,000.

As China’s largest one-stop healthcare and health management platform, Ping An Good Doctor adopts a dual strategy of health management and mobile healthcare, deeply cultivating technological innovation. It is committed to building a one-stop, full-process, O2O healthcare ecosystem centered on online medical services, while offering a broader range of standardized pan-healthcare products and one-stop health management services.

Since its launch, Ping An Good Doctor has achieved leapfrog growth, driven by its leading technological innovation capabilities, forward-looking development philosophy, and the vast growth prospects of the industry.

From a financial perspective, Ping An Good Doctor generated revenues of RMB 279 million, RMB 602 million, and RMB 1.868 billion in 2015, 2016, and 2017, respectively, maintaining a rapid growth trajectory. The company’s business lines are categorized into Family Doctor Services, Consumer Healthcare, Health Mall, and Health Management & Engagement. In 2017, these four segments accounted for 13.0%, 35.0%, 48.0%, and 4.0% of total revenue, respectively.

“The asset-heavy” model and artificial intelligence (AI) are the “decisive factors” that have enabled Ping An Good Doctor to rapidly take the lead over its peers.

Several years ago, when many internet healthcare companies operating under an “asset-light” model were seeking to transform their businesses, Ping An Good Doctor chose an expansion path opposite to that of its competitors: building its own medical team and, leveraging an open platform strategy, integrating high-quality online and offline resources across the upstream and downstream value chain.

As of December 31, 2017, Ping An Good Doctor had established an AI-assisted in-house medical team comprising nearly 1,000 healthcare professionals to deliver high-quality services powered by the company’s proprietary artificial intelligence technology. Ping An Good Doctor had also built a nationwide network of healthcare service providers, covering approximately 3,100 hospitals (including over 1,000 Grade A tertiary hospitals), as well as around 1,100 health examination centers, 500 dental clinics, and 7,500 pharmacies.

In the application of AI technology, Ping An Good Doctor has developed multiple products and features, including “Intelligent Consultation” (AI Doctor), “Facial Recognition,” “Modern Hua Tuo,” “Intelligent Image Reading,” and “Voiceprint Recognition.” The “One-Minute Clinic,” previously unveiled at the Pharmaceutical Fair, integrates offline smart medicine cabinets with online consultations provided by AI doctors.

Taking the highly anticipated intelligent consultation as an example, “AI doctors” based on big data and artificial intelligence can act as experienced online physicians during pre-diagnosis, triage, and consultation stages. They rapidly and accurately interpret users’ consultation needs, thereby helping human doctors make faster diagnoses and freeing them from repetitive, basic online consultations. Currently, through Ping An Good Doctor’s intelligent assisted diagnosis and treatment system, the consultation efficiency of full-time physicians has increased by 10 to even 50 times.

Wang Tao, Chairman, Executive Director and Chief Executive Officer of Ping An Good Doctor, highlighted the company’s investment merits by stating, “The company has already built an online-to-offline closed-loop ecosystem centered around the Ping An Good Doctor platform. Its key investment highlights include: a dominant market leadership position in China’s internet healthcare industry; a unique one-stop service model; a proprietary medical team and innovative technological solutions that deliver superior user experiences; comprehensive coverage of users’ full spectrum of health and medical needs; diversified revenue streams; a strong team of professional talent; and robust shareholder support from Ping An Group.”

Beyond its commercial value, the social value of Ping An Good Doctor is becoming increasingly prominent. As Li Yuanxiang, Deputy Chief Executive Officer and Executive Director of Ping An Insurance (02318), stated, “The establishment of Ping An Good Doctor has addressed pain points in China’s healthcare system, leveraging ‘Internet + Artificial Intelligence’ to ‘alleviate burdens on the government, hospitals, doctors, and patients.’”